REFERENCES
1. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the
diagnosis and management of syncope. Eur Heart J.2018;39(21):1883-1948.
2. Sheldon R. Tilt table testing and implantable loop recorders for
syncope. Cardiology clinics. 2013;31(1):67-74.
3. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M.
Diagnostic criteria for vasovagal syncope based on a quantitative
history. Eur Heart J. 2006;27(3):344-350.
4. Sheldon R, Rose S, Koshman ML. Comparison of patients with syncope of
unknown cause having negative or positive tilt-table tests. Am J
Cardiol. 1997;80(5):581-585.
5. Grimm W, Degenhardt M, Hoffman J, Menz V, Wirths A, Maisch B. Syncope
recurrence can better be predicted by history than by head-up tilt
testing in untreated patients with suspected neurally mediated syncope.Eur Heart J. 1997;18(9):1465-1469.
6. Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in
patients with isolated syncope and in patients with tilt-positive
syncope. Circulation. 2001;104(11):1261-1267.
7. Mallat Z, Vicaut E, Sangare A, Verschueren J, Fontaine G, Frank R.
Prediction of head-up tilt test result by analysis of early heart rate
variations. Circulation. 1997;96(2):581-584.
8. Oh JH, Kim JS, Kwon HC, et al. Predictors of positive head-up tilt
test in patients with suspected neurocardiogenic syncope or presyncope.Pacing Clin Electrophysiol. 2003;26(2 Pt 1):593-598.
9. Kazemi B, Haghjoo M, Arya A, Sadr-Ameli MA. Predictors of response to
the head-up tilt test in patients with unexplained syncope or
presyncope. Pacing Clin Electrophysiol. 2006;29(8):846-851.
10. Yiu D, Gieroba Z, Hall K, Mackintosh S, Russell A, Mangoni AA. An
early drop in systolic blood pressure predicts a positive tilt table
test in elderly patients with unexplained falls or syncope. Age
and ageing. 2006;35(2):183-185.
11. Nilsson D, Sutton R, Melander O, Fedorowski A. Spontaneous vs
nitroglycerin-induced vasovagal reflex on head-up tilt: Are there
neuroendocrine differences? Heart Rhythm. 2016;13(8):1674-1678.
12. Buszko K, Kujawski S, Newton JL, Zalewski P. Hemodynamic Response to
the Head-Up Tilt Test in Patients With Syncope as a Predictor of the
Test Outcome: A Meta-Analysis Approach. Front Physiol.2019;10:184.
13. Ghariq M, Thijs RD, Bek LM, van Zwet EW, Benditt DG, van Dijk JG. A
higher proportion of men than of women fainted in the phase without
nitroglycerin in tilt-induced vasovagal syncope. Clin Auton Res.2020.
14. Kulkarni N, Mody P, Levine BD. Abolish the Tilt Table Test for the
Workup of Syncope! Circulation. 2020;141(5):335-337.
15. van Dijk JG, Ghariq M, Kerkhof FI, et al. Novel Methods for
Quantification of Vasodepression and Cardioinhibition During
Tilt-Induced Vasovagal Syncope. Circ Res. 2020;127(5):e126-e138.
16. Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J.
The pathophysiology of the vasovagal response. Heart Rhythm.2018;15(6):921-929.
17. Sutton R, Brignole M. Twenty-eight years of research permit
reinterpretation of tilt-testing: hypotensive susceptibility rather than
diagnosis. Eur Heart J. 2014;35(33):2211-2212.
18. Bartoletti A, Alboni P, Ammirati F, et al. ’The Italian Protocol’: a
simplified head-up tilt testing potentiated with oral nitroglycerin to
assess patients with unexplained syncope. Europace.2000;2(4):339-342.
19. Eeftinck Schattenkerk DW, van Lieshout JJ, van den Meiracker AH, et
al. Nexfin noninvasive continuous blood pressure validated against
Riva-Rocci/Korotkoff. Am J Hypertens. 2009;22(4):378-383.
20. Langewouters GJ, Settels JJ, Roelandt R, Wesseling KH. Why use
Finapres or Portapres rather than intra-arterial or intermittent
non-invasive techniques of blood pressure measurement? J Med Eng
Technol. 1998;22(1):37-43.
21. Torabi P, Ricci F, Hamrefors V, et al. Impact of Cardiovascular
Neurohormones on Onset of Vasovagal Syncope Induced by Head-up Tilt.Journal of the American Heart Association. 2019;8(12):e012559.
22. Kohno R, Detloff BLS, Chen LY, Norby FL, Benditt DG. Greater early
epinephrine rise with head-up posture: A marker of increased syncope
susceptibility in vasovagal fainters. J Cardiovasc
Electrophysiol. 2019;30(3):289-296.
23. Lindenberger M, Fedorowski A, Melander O, Gallo W, Engvall J, Skoog
J. Cardiovascular biomarkers and echocardiographic findings at rest and
during graded hypovolemic stress in women with recurrent vasovagal
syncope. J Cardiovasc Electrophysiol. 2019;30(12):2936-2943.
24. Alboni P, Alboni M. Typical vasovagal syncope as a ”defense
mechanism” for the heart by contrasting sympathetic overactivity.Clin Auton Res. 2017;27(4):253-261.
25. Blanc JJ, Alboni P, Benditt DG. Vasovagal syncope in humans and
protective reactions in animals. Europace. 2015;17(3):345-349.
26. Bachus E, Holm H, Hamrefors V, et al. Monitoring of cerebral
oximetry during head-up tilt test in adults with history of syncope and
orthostatic intolerance. Europace. 2018;20(9):1535-1542.
27. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for
the management of arterial hypertension. Eur Heart J.2018;39(33):3021-3104.